MedServe LUTH Cancer Centre (MLCC)
MLCC is a high-volume outpatient oncology centre that delivers world-class cancer care to patients. Established in 2019, the centre is located within the Lagos University Teaching Hospital (LUTH), Nigeria’s premier academic medical institution.
MLCC combines state-of-the-art technology with the expertise of patient-centric clinicians to provide advanced and compassionate cancer care. The centre is transforming access to high-quality oncology services and setting new standards of excellence in cancer care.
MedServe LUTH Cancer Centre (MLCC)
MLCC is a high-volume outpatient oncology centre that delivers world-class cancer care to patients. Established in 2019, the centre is located within the Lagos University Teaching Hospital (LUTH), Nigeria’s premier academic medical institution.
MLCC combines state-of-the-art technology with the expertise of patient-centric clinicians to provide advanced and compassionate cancer care. The centre is transforming access to high-quality oncology services and setting new standards of excellence in cancer care.
OPENING HOURS
Monday – Friday: 08:00 – 17:00
CLOSING HOURS
Weekends & Public Holidays
PHONE NUMBER(S)
OPENING HOURS
Monday – Friday: 08:00 – 17:00
CLOSING HOURS
Weekends & Public Holidays
About This Facility
MLCC is one of the most advanced oncology centers in Nigeria and one of the best-equipped in West Africa, with state-of-the-art linear accelerators and the country’s only three-dimensional high dose rate (3D-HDR) brachytherapy facility. The center is staffed by ten clinical and radiation oncologists – more than any other center in the subregion; supported by a robust team of oncology nurses, medical physicists, dosimetrists, and radiation therapy technicians, the highest concentration of such oncology experience and expertise in a single site in West Africa. The center delivers modern cancer treatments ranging from radiotherapy and chemotherapy to specialized supportive care services critical to holistic cancer care. Since opening its doors in May 2019, MLCC has served over 13,000 unique cancer patients, managing an annual influx of approximately 2,500 new cases.
Our Values
At MLCC, our values shape every aspect of how we care from the way we welcome patients to the way we deliver treatment. These values guide our team, define our culture, and help us deliver world class cancer care with compassion
We redefine excellence in diagnostic care. With cutting-edge technology and a team of renowned specialists, we deliver precise, reliable, and timely results that empower informed healthcare decisions. Our commitment to ongoing education and innovation ensures we stay at the forefront of medical diagnostics, providing unparalleled accuracy and expertise in every test, every time.
Our team of medical experts is committed to alleviating the burden of diagnostic challenges by offering affordable and effective services. We provide comprehensive care at every stage of the patient’s journey and drive impactful projects that enhance access to high-quality medical services
We prioritise your care and comfort every step of the way. We understand that undergoing diagnostic tests can be a source of anxiety, and our compassionate team is dedicated to providing a seamless and supportive experience. From the moment you arrive, our patient-centric healthcare professionals will guide you through every aspect of your diagnostic journey, ensuring that your needs are met with empathy, understanding, and expertise. Our goal is to make your experience as stress-free and comfortable as possible, so you can focus on what matters most – your health and well-being.
Beyond treatment, we care about each patient’s total health. Our compassionate clinical and support teams are trained to offer care that meets emotional and physical needs at every stage
We are fueled by a passion for precision and a purpose-driven pursuit of excellence. Our team of dedicated professionals is united by a shared enthusiasm for delivering exceptional diagnostic care that makes a meaningful difference in patients' lives. With a relentless drive for innovation and a commitment to staying at the forefront of medical diagnostics, we're constantly seeking new ways to improve patient outcomes and push the boundaries of what's possible. Our team's collective energy, expertise, and compassion inspire us to strive for better every day, ensuring that every patient receives the highest level of care and attention they deserve.
MLCC's Clinical Records
Patients first. At MLCC we continuously aim to improve patient experiences.
12,482
Number of Patients Treated
7,900
Number of Chemotherapy Treatments
15,713
Number of Radiotherapy Treatments
389
Number of Brachytherapy Treatments
Clinical Capabilities
MLCC is equipped with the most innovative cancer therapy solutions, making way for curative and palliative treatments to be delivered in Nigeria. We provide patients with a multidisciplinary team approach for the management of all types of cancers and we work with highly qualified specialists across various disciplines. Allowing the facility to offer cancer care of the utmost quality.
RADIOTHERAPY (EXTERNAL RADIATION)
BRACHYTHERAPY (INTERNAL RADIATION)
CHEMOTHERAPY
IMMUNOTHERAPY
Frequently Asked Questions
MLCC provides specialist cancer care including consultations, chemotherapy, radiotherapy, brachytherapy, and immunotherapy. We also offer supportive services such as a nutrition clinic, counselling, and access to a patient support group.
You can register by visiting the Front Desk at the Centre or online via the registration link at the top of our website. You will need your referral letter, histopathology report, and other relevant medical records to complete registration.
For first-time appointments, registration must be completed first. After registering, you can book appointments: In person at the MLCC Front Desk, Online via our website, By email: frontdesk@nlcc.ng, By phone: +234 700 674 2588, +234 903 000 9438, +234 903 000 9436
Yes. MLCC offers virtual consultations for both first-time and follow-up patients. To schedule, call or visit the Front Desk.
Payment options at MLCC include:
● Self-payment (via debit card, bank transfer, or direct deposit)
● Health Maintenance Organisation (HMO) coverage – see our website or inquire at the Front Desk for the current list of accepted HMOs
● International insurance – subject to verification; please contact the front desk for assistance
No, MLCC does not currently accept NHIS Insurance Cover. However, some HMOs that partner with NHIS may be accepted. Please refer to our list of accepted HMOs or check with your HMO provider.
Yes. MLCC runs the Indigent Support Program (NISP) to help patients in financial need. Screening and application are required. Please ask at the front desk for details.
We are open Monday to Friday, from 8:00 AM to 5:00 PM. MLCC is closed onpublic holidays, and any changes in operation hours will be communicated in advance
You need to come with:
● Your referral letter
● Histopathology report
● Any other recent and relevant medical records such as:
● Immunohistochemistry report
● MRI report
● CT scan
● These documents are essential for registration and medical evaluation
MLCC is an outpatient clinic; we do not have inpatient wards or overnight facilities. However, Hospital Admissions are available at Alima Attah Oncology Wards in LUTH, just beside our centre. You can also explore our carefully curated list of nearby accommodation options here
Always ensure you confirm your next appointment with your doctor during your visit. After that, you can:
● Book at the Front Desk before you leave
● Call us at +234 700 674 2588, +234 903 000 9436, +234 903 000 9438
● Send us a WhatsApp message: +234 901 834 7789
● Send us an email: frontdesk@nlcc.ng
Facility Accreditation
The center has been recognized for its impact, having been awarded the National Health Excellence Awards (NHEA) Most Outstanding Oncology Center Award three years in a row – 2023, 2024, and 2025.
Three time winner of the NHEA prize for Most Outstanding Oncology Centre of the Year (2023, 2024 & 2025)
ESMO (European Society for Medical Oncology) Designated Centre of Integrated Oncology and Palliative Care for 2025 – 2027